HilleVax to be acquired by XOMA Royalty for $1.95 per share plus contingent value right

HilleVax, Inc.

XOMA Royalty to acquire HilleVax in cash tender offer at $1.95 per share plus one CVR per share.
HilleVax Board unanimously approved the merger, recommending stockholders tender shares.
Support agreements cover ~22.9% of outstanding HilleVax shares, with stockholders agreeing to tender.
HilleVax terminated its license agreement with Takeda Vaccines, effective six months after notice.
Minimum cash condition: HilleVax must have at least $102.95 million net cash at closing.

item 1.01item 1.02item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.